Company Overview
Core Molding Technologies, Inc. operates as a manufacturer of thermoplastic and thermoset structural products, utilizing a diverse range of processes including sheet molding compound compression molding across the United States, Mexico, Canada, and international markets. The company functions within the Basic Materials sector, specifically serving the Specialty Chemicals industry, which positions it as a provider of essential raw materials and components for broader industrial applications. Its scale is defined by a market capitalization of $184.70M and an annual revenue of $273.80M, supported by an organizational structure of 1,239 employees. These valuation and revenue figures indicate that the company maintains a mid-cap status, suggesting it has established a significant operational footprint without yet reaching the massive scale of large-cap industrial peers, thereby potentially offering distinct risk-return characteristics to the market.
Financial Health
The company reported a trailing twelve-month revenue of $273.80M with a corresponding net income of $11.20M and an EBITDA of $28.02M, revealing a cost structure where operating expenses and taxes consume approximately 59% of total revenue before reaching the bottom line. Free cash flow stands at -$1.73M, which indicates a temporary liquidity constraint where capital expenditures or working capital requirements currently exceed the cash generated from operations, limiting immediate financial flexibility for expansion without external financing. Margin analysis shows a gross margin of 17.4%, an operating margin of 5.0%, and a profit margin of 4.1%, highlighting that while the company retains value from production, significant overhead costs and tax burdens reduce the final profitability per dollar of sales. On the balance sheet, the firm holds $38.07M in cash against $34.55M in debt, resulting in a debt-to-equity ratio of 21.84, which suggests a leveraged position where equity capital is a smaller cushion relative to the debt load than the cash-on-hand would imply if viewed in isolation. Liquidity is robust as evidenced by a current ratio of 3.02, indicating that the company possesses more than three times the current assets necessary to cover its short-term obligations. Return on equity is 7.3% and return on assets is 4.5%, metrics that reveal management generates moderate returns on the capital invested by shareholders and the total asset base, reflecting a standard efficiency profile for the specialty chemicals sector.
Valuation Assessment
Valuation metrics include a trailing twelve-month P/E ratio of 16.21 and a forward P/E of 12.16, implying that the market expects earnings growth that would justify a lower multiple in the future compared to historical performance. The price-to-book ratio is 1.13, indicating that the company trades at a slight premium over its book value, suggesting investors value the firm's intangible assets or growth potential slightly above the net asset liquidation value. Alternative valuation measures include a price-to-sales ratio of 0.67 and an EV/EBITDA of 6.21, which suggest the stock is priced conservatively relative to its sales volume and earnings power before interest, taxes, depreciation, and amortization. The 52-week trading range spans from a low of $13.99 to a high of $22.29; without a specific current share price provided in the data, the precise percentage distance from the high cannot be calculated, but the range defines the volatility envelope within which the stock has traded over the past year. The beta value of 0.46 indicates that the stock exhibits low price volatility relative to the broader market, moving less than half as much as the market index during typical periods of fluctuation.
Growth & Income
Revenue growth for the year over year stands at 19.5%, while earnings growth is listed as N/A, meaning a direct comparison of earnings velocity versus revenue velocity is not possible with the available data, though the revenue expansion suggests a growing top line. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm retains all of its net income rather than distributing cash to shareholders. Consequently, the company reinvests its earnings back into operations, capital projects, or debt reduction to fuel future growth rather than providing immediate income to investors. This profile presents a growth-oriented investment case where returns are derived solely from capital appreciation and operational expansion rather than a combination of dividends and share price gains.